🇺🇸 FDA
Patent

US 6153430

Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers

expired A61KA61K2039/505A61K2123/00

Quick answer

US patent 6153430 (Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K2123/00, A61K47/6851, A61K47/6869